Transcription factor Hoxb5 reprograms B cells into functional T lymphocytes.

Area of Science:

• Immunology
• Developmental Biology
• Cellular Reprogramming

Background:

• B cells and T cells are distinct lymphocytes crucial for adaptive immunity.
• Hematopoietic stem cells differentiate into various blood cell types, including B and T cells.
• Master regulators typically dictate lineage commitment in hematopoietic cells.

Purpose of the Study:

• To investigate if a transcription factor can reprogram B cell lineage to T cell lineage.
• To identify factors capable of inducing B cell to T cell fate conversion in vivo.
• To explore the potential of de novo T cell generation through cellular reprogramming.

Main Methods:

• Utilized the transcription factor Hoxb5 for cellular reprogramming experiments.
• Administered Hoxb5 to pro-pre-B cells to induce lineage conversion.
• Analyzed reprogrammed cells for T cell characteristics using transcriptomics and functional assays.
• Tracked the reprogramming process from bone marrow to thymus.

Main Results:

• Hoxb5 successfully reprogrammed pro-pre-B cells into functional early T cell lineage progenitors.
• Reprogramming occurred in vivo, initiating in the bone marrow and completing in the thymus.
• Generated T lymphocytes exhibited characteristics mirroring natural T cells in transcriptome, differentiation, distribution, and function.
• Hoxb5 repressed B cell genes and activated T cell regulators, driving the fate conversion.

Conclusions:

• Hoxb5 can reprogram B cell fate to T cell fate in vivo.
• This study presents a novel paradigm for de novo generation of functional T cells.
• The findings have significant implications for regenerative medicine and immunotherapy.